Use of fluorescein diacetate (FDA) staining to detect viable Mycobacterium tuberculosis

Bangladesh Journal of Medical Science

Volumn 11, Issue 4, 2012, Pages 322-330

  Islam, Shamima ^a   Rahman, Farjana ^b   Saurab, Kisore Munshi ^b   Ahmed, Jewel ^c   Kamal, S M Mostafa ^d   Noor, Rashed ^b  

^a Regional Tuberculosis Reference Laboratory (RTRL)   (Bangladesh)

^b STAMFORD UNIVERSITY BANGLADESH   (Bangladesh)

^c University Research Co   (Bangladesh)

^d NIDCH   (Bangladesh)

Author keywords

Auramine O staining; Fluorescein diacetate staining; Lowenstein Jensen culture; Multi drug resistance; Tuberculosis

Indexed keywords

AURAMINE; FLUORESCEIN DIACETATE; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ARTICLE; BACTERIAL VIABILITY; BACTERIUM CULTURE; BACTERIUM DETECTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FLUORESCENCE MICROSCOPY; GOLD STANDARD; GRAM STAINING; LIGHT EMITTING DIODE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREDICTIVE VALUE; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; TREATMENT FAILURE;

EID: 84870382272     PISSN: 22234721     EISSN: 20760299     Source Type: Journal    
DOI: 10.3329/bjms.v11i4.12605     Document Type: Article

References (33)

1. Ryan, F. The forgotten plague: how the battle against tuberculosis was won and lost. Boston: Little, Brown and Co 1992; pp. 3.
2. World Health Organization. Tuberculosis. Fact sheet No 104. Geneva: World Health Organization, 2007.
3. Marjorie P, Golden MD, Holne AR and Vikram MD. Extrapulmonary Tuberculosis. Mayo Clinic, Scottsdale, Arizona. Am Fam Physician 2005; 72(9): 1761-1768. PMid:16300038
4. World Health Organization. Global Tuberculosis Control. Report. Geneva: World Health Organization, 2003.
5. Jasmer RM, Nahid P and Hopewell PC. Clinical practice. Latent tuberculosis infection. N Engl J Med 2002; 347(23): 1860-1866. http://dx.doi.org/10.1056/NEJMcp021045 PMid:12466511
6. Zaman K, Yunus M, Arifeen SE, Baqui AH, Sack DA, Hossain S, et al. Prevalence of sputum smearpositive positive tuberculosis in a rural area in Bangladesh. Epidemiol Infect 2006; 134(5): 1052-1 0 5 9. h t t p: / / d x. d o i. o r g / 1 0. 1 0 1 7 / S 0 9 5 0 2 6 8 8 0 6 0 0 6 1 0 8 P M i d: 1 6 5 6 9 2 7 1 PMCid:2870495
7. Michael D, Iseman MD, Leonid B and Heifets MD. Rapid detection of tuberculosis and drug resistant tuberculosis. The New Eng J Med 2006; 355(15): 1606-1608. http://dx.doi.org/10.1056/ NEJMe068173PMid:17035655
8. Kadival GV, Kameswaran M and Ray MK. Radioimmunoassay antibody detection in pulmonary tuberculosis. Ind J Tub 2000; 47: 97.
9. Sharma SK, Kumar S, Saha PK, George N, Arora SK, Gupta D, et al. Prevalence of multidrug-resistant tuberculosis among Category II pulmonary tuberculosis patients. Indian J Med Res 2011; 133: 312-315 PMid:21441686 PMCid:3103157
10. Vourinen P, Miettinen A, Vuento R and Hallstrom O. 1995). Direct detection of Mycobacterium tuberculosis complex in respiratory specimens by gene-probe amplified Mycobacterium Tuberculosis direct test and roche amplicor Mycobacterium Tuberculosis Test. J Clin Microbiol 1995; 33: 1856-1859. PMid:7665659 PMCid:228285
11. Rahman F, Munshi SK, Kamal SMM, Rahman ASMM, Rahman MM, Noor R. Comparison of Different Microscopic Methods with Conventional TB Culture. S J Microbiol 2011; 1(1): 51-55. http://dx.doi.org/10.3329/ sjm.v1i1.9133
12. Moore DAJ, Mendoza D and Gilman RH. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resourcepoor settings. J Clin Microbiol 2004; 42: 4432-4437. h t t p: / / d x. d o i. o r g / 10.1128/JCM.42.10.44324437.2004 PMid:15472289 PMCid:522377
13. Parvez MKN, Hasan M, Rumi S, Ahmed M, Salimullah Y, Tahera DJ, et al. PCR can help early diagnosis of pulmonary tuberculosis. Southeast Asian J Trop Med Public Health 2003; 34(1):147-153.
14. Kommareddi S, Abramowsky C, Swinehart G and Hrabak L. Nontuberculous mycobacterial infections: comparison of the fluorescent auramine-O and Ziehl-Neelsen techniques in tissue diagnosis. Hum Pathol 1 9 8 4; 15(11):1085-1089. http://dx.doi.org/10.1016/S0046-8177(84)80253-1
15. Truffot-Pernot C, Véziris N and Sougakoff W. Modern diagnosis of tuberculosis. Presse Med 2006; 35(11):1739-1746. http://dx.doi.org/ 10.1016/S07554982(06)74892-8
16. Kvach JT and Veras JR. A fluorescent staining procedure for determining the viability of mycobacterial cells. Int J Leprosy 1982; 50: 183-192.
17. Harada S and Numata N. Application of FDA/EB staining for the detection of viable or non-viable mycobacteria in clinical specimens. Kekkaku 1992; 67: 113-117. PMid:1372666
18. Salim AH, Aung KJM, Hossain MA and Van Deun A. Early and Rapid Microscopy-Based Diagnosis of the treatment failure and MDR-TB. Int J Tuberc Lung Dis 2006;10(11):1248-1554. PMid:17131784
19. Chang KC, Yew WW and Chan RCY. Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2010; 8: 1-11.
20. Zapata P, Arbeloa M and Aznar J. Evaluation of mycobacteria growth indicator tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis isolates from clinical specimens. Clin Microbiol Infect 1999; 5: 227-230. h t t p: / / d x. d o i. o r g / 1 0. 1 1 1 1 / j. 1 4 6 9-0691.1999. tb00129. x
21. Johnson R, Streicher E, Louw MG, Warren ERM, van Helden, PD and Victor TC. Drug resistance in Mycobacterium tuberculosis. Curr Issues Mol Biol 2004; 8: 97-112.
22. Tsukiyama F., Katoh M. and Matsuo Y. Modification of the fluorescent staining method for mycobacterial cells. Hiroshima J Med Sci 1984; 33: 293-295. PMid:6384149
23. De Kantor IN, Kim SJ, Friden T, Lazlo A, Norvel PY, Reider H, et al. Ziehl-Neelsen staining. In Laboratory services in tuberculosis control-Microscopy, 2nd ed. Geneva: World Health Organization, 1998: 27-29.
24. Kausar MA. Fundamentals of Medical Sciences. 2nd ed. Asian color printing 2008: 79-81.
25. Freiden TE., Sterling T, Pablos-Mendez A., Kilburn JO, Frieden TR., Sterling TR, et al. Tuberculosis. Lancet 2003; 362: 887-899. http://dx.doi.org/10.1016/S0140-6736(03)14333-4
26. World Health Organization (WHO). WHO statement on BCG revaccination for the prevention of tuberculosis. Geneva: World Health Organization, 1995.
27. Murray CJ and Salomon JA. Modeling the impact of global tuberculosis control strategies. Proc Natl Acad Sci USA 1998; 95: 13881-13886. http://dx.doi.org/10.1073/pnas.95.23.13881
28. World Health Organization (WHO). Tuberculosis (TB). Report. Geneva: World Health Organization, 2009.
29. Marras K. Tuberculosis among tibetan refugee claimants inToronto, 1998 to 2000. Chest 1998; 124: 915-921. http://dx.doi.org/10.1378/chest.124.3.915 PMid:12970017
30. Kamal SMM, Ahsan HM, Ahmed S, Ayaz K, Mahbub KS, Khan MAI, et al. Isolation and Identification of Mycobacterium from Extra-pulmonary Specimen at NTRL, NIDCH. J Med 2010; 11: 128-130.
31. Rattan A, Kalia A and Ahmad N. Multidrugresistant Mycobacterium tuberculosis: molecular perspectives. Emerg Infect Dis 1998; 4: 195-209. http://dx.doi.org/10.3201/eid0402.980207 PMid:9621190 PMCid:2640153
32. Shiferaw G, Woldeamanuel Y, Gebevehu M, Girmachew F, Demessie D and Lemma E. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2007; 45(4): 1093-1 0 9 7. h t t p: / / d x. d o i. o rg/10.1128/JCM.01949-06 PMid:17251409 PMCid:1865834
33. Azad Chowdhury MAK. Evolving antibiotic resistance: a great threat to medical practice. Bangladesh Journal of Medical Science 2012; 11(01): 001-003. DOI: http://dx.doi.org/10.3329/bjms.v11i1.9814